Exosome Diagnostics Enters Collaboration Agreement with Lilly for BloodBased Biomarker Discovery

Exosome Diagnostics has entered into a collaboration agreement with Eli Lilly and Company for biomarker discovery and validation using Exosome Diagnostics proprietary EXO50 nucleic acid extraction kit…
Read the full story: Bioportfolio Biomarker News